The Conversation: Sharona Hoffman, the Edgar A. Hahn Professor of Law and co-director of the Law-Medicine Center, discusses the shortcomings of specialty drugs—those that treat complex conditions such as cancer and multiple sclerosis. Republished by: , , , .
